Weight · Rx required

The Needle-Free Stack

All the science, none of the pokes.

Tier 1 · FDA-approved / strong evidence

The story

All the science, none of the pokes. The same GLP-1 medications, in under-the-tongue drops for people who'd rather skip injections.

Why this combination

Not a different drug — the same semaglutide or tirzepatide in a sublingual form, for needle-averse people who might otherwise never start.

What to expect

The active ingredients have the strong trial record above. Honest note: most trial evidence used injections, and absorption from compounded sublingual forms can differ, so your provider guides expectations and dosing. The appeal is adherence — the best medication is the one you'll actually take.

Risks & considerations

Same GLP-1 side-effect and contraindication profile (gastrointestinal effects, thyroid-tumor boxed warning, rare pancreatitis/gallbladder issues). Because compounded sublingual delivery is less studied than the injectable trials, absorbed dose is less predictable — another reason for provider oversight.

Sources

  1. STEP 1, NEJM 2021
  2. SURMOUNT-1, NEJM 2022

What's in the stack

  • Semaglutide or tirzepatide sublingual drops